Aprea Therapeutics Inc (APRE) — Financial Flexibility Index
Aprea Therapeutics Inc (APRE) has a Financial Flexibility Index of -0.88x as of December 2025. Free cash flow of $-3.07 Million (operating CF $-3.07 Million minus capex $0.00) represents -1% of total liabilities ($3.49 Million). Also explore APRE shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aprea Therapeutics Inc Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Aprea Therapeutics Inc across 10 annual periods. Check asset allocation strategy of Aprea Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Aprea Therapeutics Inc (2007–2025)
Year-by-year free cash flow to debt coverage for Aprea Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Aprea Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.69x | $-12.89 Million | $-12.89 Million | $3.49 Million | ▼ -27.4% |
| 2024 | -2.90x | $-13.54 Million | $-13.56 Million | $4.67 Million | ▼ -5.2% |
| 2023 | -2.76x | $-12.08 Million | $-12.18 Million | $4.39 Million | ▲ +50.3% |
| 2022 | -5.54x | $-25.01 Million | $-25.01 Million | $4.51 Million | ▼ -7.6% |
| 2021 | -5.15x | $-37.69 Million | $-37.69 Million | $7.32 Million | ▼ -90.0% |
| 2020 | -2.71x | $-41.78 Million | $-41.80 Million | $15.41 Million | ▲ +4.8% |
| 2019 | -2.85x | $-26.68 Million | $-26.71 Million | $9.36 Million | ▼ -2094.8% |
| 2018 | -0.13x | $-15.25 Million | $-15.25 Million | $117.46 Million | ▲ +43.9% |
| 2017 | -0.23x | $-14.00 Million | $-14.00 Million | $60.53 Million | ▲ +70.4% |
| 2007 | -0.78x | $-1.90 Million | $-1.90 Million | $2.43 Million | — |